Physician profile
Barbara Culton
NPI 1073700597
$4,918.09
in general payments reported to CMS, 2019-2025
46 companies · $1,405 in 2025
The $1,405 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $870 · 2022: $723 · 2023: $954 · 2024: $966 · 2025: $1,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,225 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,224.70 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $593.19 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals Lp | $544.14 | 2021-2025 | Tezspire, Lynparza, Bevespi Aerosphere |
| Novartis Pharmaceuticals Corporation | $353.47 | 2021-2025 | |
| Astellas Pharma US INC | $322.53 | 2021-2025 | Xtandi, Vyloy |
| Janssen Biotech, INC. | $263.13 | 2021-2025 | Erleada, Balversa, Akeega |
| Pfizer INC. | $253.59 | 2021-2025 | |
| Lilly USA, LLC | $207.65 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Aveo Pharmaceuticals, INC. | $165.89 | 2022-2025 | Fotivda |
| Takeda Pharmaceuticals U.S.A., INC. | $152.44 | 2021-2025 | Alunbrig, Fruzaqla |
| Sobi, INC | $151.92 | 2022-2023 | |
| Incyte Corporation | $138.15 | 2021-2025 | Zynyz, Monjuvi, Jakafi |
| Abbvie INC. | $124.99 | 2021 | |
| Jazz Pharmaceuticals INC. | $116.79 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $110.41 | 2023 | Odomzo, Yonsa |
| Seagen INC. | $102.67 | 2021-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Culton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.